Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 11/20 | 0.52 |
| ▸ | MEN1 | O00255 | 7/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.52 |
| ▸ | HTT | P42858 | 6/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.42 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2862811 | 0.85 | DHFR (0.46) | MAPTMEN1KMT2ALMNATDP1 | |
| SCHEMBL2869867 | 0.82 | KMT2A (0.56) | MAPTMEN1KMT2AHTTLMNA | |
| SCHEMBL2867194 | 0.78 | MAPT (0.47) | MAPTMEN1KMT2AHTTLMNA | |
| SCHEMBL27643406 | 0.77 | MAPT (0.50) | MAPTMEN1KMT2AHTTLMNA | |
| SCHEMBL2868251 | 0.75 | MAPT (0.50) | MAPTMEN1KMT2AHTTLMNA | |
| SCHEMBL2861009 | 0.74 | ABCG2 (0.54) | MAPTMEN1KMT2AHTTLMNA | |
| SCHEMBL2858919 | 0.72 | MEN1 (0.61) | MAPTMEN1KMT2AHTTLMNA | |
| SCHEMBL1285054 | 0.72 | APP (0.60) | MAPTMEN1KMT2AHTTLMNA | |
| SCHEMBL2860819 | 0.70 | DHFR (0.54) | MAPTMEN1KMT2ALMNAL3MBTL1 | |
| SCHEMBL6237367 | 0.69 | CYP1A2 (0.51) | MAPTMEN1KMT2AHTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7803898-B2 | Aminoquinoxaline compound, polyaminoquinoxaline compound, and use thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20090030176-A1 | Aminoquinoxaline Compound, Polyaminoquinoxaline Compound, and Use Thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1705178-A1 | AMINOQUINOXALINE COMPOUND, POLYAMINOQUINOXALINE COMPOUND, AND USE THEREOF | Nissan Chemical Industries, Ltd. (JP) | 2006-09-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090030176-A1 | Aminoquinoxaline Compound, Polyaminoquinoxaline Compound, and Use Thereof | PAM, CYC1, QPCT | MAPT 4450/4885MEN1 386/4885KMT2A 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.